KOzZTM1 —
. /|rthroCare £2
CORPORATION poe 3
ocT 03 2002
510(k) Summary
ArthroCare Corporation
ArthroCare® Electrosurgery Wands

General Information
Submitter Name/Address: ArthroCare Corporation

680 Vaqueros Avenue

Sunnyvale, CA 94085-2936
Establishment Registration Number: 2951580
Contact Person: Valerie Defiesta-Ng

Director, Regulatory Affairs
Date Prepared: July 26, 2002
Device Description
Trade Name ArthroCare Electrosurgery Wands
Generic/Common Name: Electrosurgical Device and Accessories
Classification Name: Electrosurgical Cutting and Coagulation

Device and Accessories (21 CFR

878.4400)
Predicate Devices
ArthroCare Electrosurgery Wands K020622; cleared on March 28, 2002
Product Description
The Wands are bipolar, single use, high frequency electrosurgical device designed for
specific indications.

ix
680 Vaqueros Avenue * Sunnyvale, CA 94085 * (408) 736-0224 © Fax: (408) 736-0226

Ko2UN78
pp Ch t of a
Intended Use
The Electrosurgery Wands are indicated for resection, ablation, and coagulation of soft
tissue and hemostasis of blood vessels in open, laparoscopic, and endoscopic general
surgery and general gynecology procedures. Representative procedures include the
following:
|
Substantial Equivalence
This Special 510(k) proposes modification in material for the Electrosurgery Wands,
which were previously cleared under K020662, on March 28, 2002. The indications for
use, technology, principle of operation, design, performance and dimensional
specifications, labeling, packaging, and sterilization parameters of the ArthroCare
Electrosurgery Wands remain the same as in the predicate cleared 510(k).
Summary of Safety and Effectiveness
The modified Electrosurgery Wands, as described in this submission, are substantially
equivalent to the predicate Electrosurgery Wands. The proposed modification in material
is not a substantial change or modification, and does not significantly affect the safety or
efficacy of the devices.
x

eomte
f LC DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
Ne I 00
Mint : Food and Drug Administration
: 9200 Corporate Boulevard
: Rockville MD 20850
| OCT 03 2002 |

Arthocare Corporation
Valerie Defiesta-Ng
Director, Regulatory Affairs
680 Vaqueros Avenue
Sunnyvale, California 94085
Re: K022475

Trade/Device Name: Modification to Arthrocare Controller (System 2000 and 8000)

Regulation Number: 878.4400

Regulation Name: Electrosurgical cutting and coagulation device and accessories

Regulatory Class: Class I

Product Code: GEI

Dated: September 11, 2002

Received: September 12, 2002
Dear Ms. Defiesta-Ng:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class I] (Special Controls) or class ITI (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that DA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencics. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 — Ms. Valerie Defiesta-Ng .
This letter will allow you to begin marketing your device as described in your Section 510(k) ~
_ premarket notification. The FDA finding of substantial equivalence of your‘device to a legally
. marketed predicate device results in a classification for your device and thus, permits your device to

proceed to the market. :
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and |
additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of
Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of
your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the
regulation entitled, “Misbranding by reference to premarket notification” (21 CFR Part 807.97).
Other general information on your responsibilities under the Act may be obtained from the Division
of Small Manufacturers, International and Consumer Assistance at its toll-free number (800)
638-2041 or (301) 443-6597 or at its Internet address
http:/Avww.fda.gov/cdrh/dsma/dsmamain.htm]

Sincerely yours,

at oh. ay /,

CeliaM. Witten, Ph.D., M.D.

Director

Division of General, Restorative

and Neurological Devices

Office of Device Evaluation

Center for Devices and Radiological Health
Enclosure

, Indications for Use Statement — : Device Name: ArthroCare” Electrosurgery Wands
510(k) Number: K g22475.
Indications for use:
The Electrosurgery Wands are indicated for resection, ablation, and coagulation of soft
tissue and hemostasis of blood vessels in open, laparoscopic, and endoscopic general
surgery and general gynecology procedures. Representative procedures include the
following:
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED}
. Concurrence of SPB el ation (ODE)

Prescription Use x LAER 4 (Qvef-the-Counter
(Per 21 CFR (Division Sign-Off) ~ —_—
801.109) Division of General, Restorative

and Neurological Devices

j —
510(k) Number__(0 2 24 7.S viii

